- Home
- THW vs SLDB Comparison
THW vs SLDB Comparison
Compare THW & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THW
- SLDB
- Stock Information
- Founded
- THW 2015
- SLDB 2013
- Country
- THW United States
- SLDB United States
- Employees
- THW N/A
- SLDB N/A
- Industry
- THW Finance Companies
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- THW Finance
- SLDB Health Care
- Exchange
- THW Nasdaq
- SLDB Nasdaq
- Market Cap
- THW 405.3M
- SLDB 234.8M
- IPO Year
- THW N/A
- SLDB 2018
- Fundamental
- Price
- THW $10.62
- SLDB $2.87
- Analyst Decision
- THW
- SLDB Strong Buy
- Analyst Count
- THW 0
- SLDB 9
- Target Price
- THW N/A
- SLDB $15.67
- AVG Volume (30 Days)
- THW 149.9K
- SLDB 1.5M
- Earning Date
- THW 01-01-0001
- SLDB 05-19-2025
- Dividend Yield
- THW 10.76%
- SLDB N/A
- EPS Growth
- THW N/A
- SLDB N/A
- EPS
- THW N/A
- SLDB N/A
- Revenue
- THW N/A
- SLDB N/A
- Revenue This Year
- THW N/A
- SLDB N/A
- Revenue Next Year
- THW N/A
- SLDB $569.02
- P/E Ratio
- THW N/A
- SLDB N/A
- Revenue Growth
- THW N/A
- SLDB N/A
- 52 Week Low
- THW $9.76
- SLDB $2.45
- 52 Week High
- THW $14.89
- SLDB $10.99
- Technical
- Relative Strength Index (RSI)
- THW 44.06
- SLDB 42.95
- Support Level
- THW $10.51
- SLDB $2.52
- Resistance Level
- THW $10.98
- SLDB $4.35
- Average True Range (ATR)
- THW 0.16
- SLDB 0.45
- MACD
- THW 0.03
- SLDB -0.01
- Stochastic Oscillator
- THW 40.00
- SLDB 18.71
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.